EGFR c-Met Pharmaceutical composition for a combination therapy containing an EGFR antagonist and anti-c-Met antibody

摘要

Provided is a pharmaceutical composition for concomitant administration for the prevention and / or treatment of c-Met or EGFR-induced diseases comprising an EGFR antagonist and an anti-c-Met antibody as an active ingredient. The pharmaceutical composition for concomitant administration not only shows an excellent synergistic effect, but can also exert an effect even when resistant to EGFR antagonists, thereby enabling more effective treatment.